4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001209191-23-027507
Options or other derivatives
- Director acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kunkel Lori Anne · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-05-04 | Grant or award : show line 1 in the form Director Stock Option (right to buy) | +25,000 | 25,000 | D |
Loading xslF345X04/doc4.xml…